quotes
Like a business war epic! The latest developments in the battle for the "rising star of weight-loss drugs" among industry giants are here!
[Introduction] Pfizer An amendment to the merger agreement with Metsera was reached, valuing Metsera at up to $86.25 pe...
Stock
2026-01-12
A crucial bidding war for weight-loss drugs: Pfizer may raise its bid to compete with Novo Nordisk for Metsera.
The bidding war surrounding obesity biotechnology company Metsera is intensifying, with reports indicating that Pfizer....
Stock
2026-01-12
